blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0453337

EP0453337 - Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.08.1998
Database last updated on 03.09.2024
Most recent event   Tooltip20.11.2009Change - representativepublished on 23.12.2009  [2009/52]
Applicant(s)For all designated states
Salkin, André
Le Fresnay, Fresne le Plan
F-76520 Boos / FR
[1991/43]
Inventor(s)01 / Salkin, André
Le Fresnay, Fresne Le Plan
F-76520 Boos / FR
[1991/43]
Representative(s)Portal, Gérard, et al
Cabinet Beau de Loménie
158, rue de l'Université
75340 Paris Cedex 07 / FR
[N/P]
Former [2009/52]Portal, Gérard, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cedex 07 / FR
Former [1991/43]Portal, Gérard, et al
Cabinet Beau de Loménie 158, rue de l'Université
F-75340 Paris Cédex 07 / FR
Application number, filing date91400743.020.03.1991
[1991/43]
Priority number, dateFR1990000494518.04.1990         Original published format: FR 9004945
[1991/43]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report 
No.:EP0453337
Date:23.10.1991
Language:FR
[1991/43]
Type: A3 Search report 
No.:EP0453337
Date:25.11.1992
Language:FR
[1992/48]
Type: B1 Patent specification 
No.:EP0453337
Date:01.10.1997
Language:FR
[1997/40]
Search report(s)(Supplementary) European search report - dispatched on:EP05.10.1992
ClassificationIPC:A61K31/505, A61K31/71, A61K31/14, A61K31/155, // (A61K31/71, 31:505),(A61K31/505, 31:155),(A61K31/505, 31:14)
[1992/48]
CPC:
A61K31/70 (EP); A61K31/14 (EP); A61K31/155 (EP);
A61K31/495 (EP); A61K31/505 (EP); A61P27/02 (EP);
A61P31/04 (EP) (-)
C-Set:
A61K31/14, A61K2300/00 (EP);
A61K31/155, A61K2300/00 (EP);
A61K31/505, A61K2300/00 (EP);
A61K31/505, A61K31/14 (EP);
A61K31/505, A61K31/155 (EP);
A61K31/70, A61K2300/00 (EP);
A61K31/70, A61K31/505 (EP)
(-)
Former IPC [1991/43]A61K31/505
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/43]
TitleGerman:Verwendung von Hexetidin oder dessen Derivaten oder Salzen zur Herstellung einer pharmazeutischen Zusammensetzung für ophthalmische Verwendung[1991/43]
English:Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use[1991/43]
French:Utilisation de l'héxétidine ou de ses dérivés ou sels pour la préparation d'une composition pharmaceutique à usage ophtalmologique[1991/43]
Examination procedure17.05.1993Examination requested  [1993/28]
30.07.1993Despatch of a communication from the examining division (Time limit: M04)
18.11.1993Reply to a communication from the examining division
22.12.1993Despatch of a communication from the examining division (Time limit: M06)
20.06.1994Reply to a communication from the examining division
12.08.1994Despatch of a communication from the examining division (Time limit: M02)
20.10.1994Reply to a communication from the examining division
24.11.1995Despatch of a communication from the examining division (Time limit: M02)
29.01.1996Reply to a communication from the examining division
23.01.1997Despatch of communication of intention to grant (Approval: Yes)
24.03.1997Communication of intention to grant the patent
30.05.1997Fee for grant paid
30.05.1997Fee for publishing/printing paid
Opposition(s)02.07.1998No opposition filed within time limit [1998/39]
Fees paidRenewal fee
18.03.1993Renewal fee patent year 03
18.03.1994Renewal fee patent year 04
21.03.1995Renewal fee patent year 05
20.03.1996Renewal fee patent year 06
20.03.1997Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGR01.10.1997
[2000/05]
Documents cited:Search[X]GB793379  (WARNER LAMBERT PHARMACEUTICAL);
 [Y]EP0136231  (SALKIN ANDRE)
 [Y]  - R. DOLDER ET COLL. (EDITEURS) 'Ophthalmika' 1983 , WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT MBH , STUTTGART, DE
    [ ] - R. DOLDER ET COLL. (EDITEURS) 'Ophthalmika' 1983 , WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT MBH , STUTTGART, DE
Examination   - R.Dolder et coll.(Editeurs) 'Ophthalmika' Wissenschaftliche Verlagsgesellschaft Mbh, Stuttgart, DE, pages 55-67, 92-94, 477-482
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.